(Q44770380)

English

Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis

scientific article published on 18 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis (English)

1 reference

Europe PubMed Central

6 December 2017

refractory anemia

1 reference

based on heuristic

inferred from title

object named as

M Rozman

7

0 references

Torsten Haferlach

10

object named as

T Haferlach

1 reference

Europe PubMed Central

6 December 2017

author name string

J Broséus

1

1 reference

Europe PubMed Central

6 December 2017

T Alpermann

2

1 reference

Europe PubMed Central

6 December 2017

M Wulfert

3

1 reference

Europe PubMed Central

6 December 2017

L Florensa Brichs

4

1 reference

Europe PubMed Central

6 December 2017

S Jeromin

5

1 reference

Europe PubMed Central

6 December 2017

E Lippert

6

1 reference

Europe PubMed Central

6 December 2017

F Lifermann

8

1 reference

Europe PubMed Central

6 December 2017

V Grossmann

9

1 reference

Europe PubMed Central

6 December 2017

U Germing

11

1 reference

Europe PubMed Central

6 December 2017

E Luño

12

1 reference

Europe PubMed Central

6 December 2017

F Girodon

13

1 reference

Europe PubMed Central

6 December 2017

S Schnittger

14

1 reference

Europe PubMed Central

6 December 2017

MPN and MPNr-EuroNet (COST Action BM0902)

15

1 reference

Europe PubMed Central

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 April 2013

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

27

1 reference

Europe PubMed Central

6 December 2017

9

1 reference

Europe PubMed Central

6 December 2017

1826-1831

1 reference

Europe PubMed Central

6 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2013.120

0 references

Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

The role of JAK2 mutations in RARS and other MDS.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

JAK2 V617F and ringed sideroblasts: not necessarily RARS-T.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Frequent pathway mutations of splicing machinery in myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Spliceosome-related gene mutations in myelodysplastic syndrome can be used as stable markers for monitoring minimal residual disease during follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

JAK2V617F mutational frequency in polycythemia vera: 100%, >90%, less?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

The JAK2 V617F mutation is rare in RARS but common in RARS-T

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

21 January 2018

The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the spliceosome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2013.120

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44770380&oldid=2040244736"